
Journal of the American Chemical Society p. 5607 - 5618 (1994)
Update date:2022-09-26
Topics:
Boger, Dale L.
Colletti, Steven L.
Honda, Takeshi
Menezes, Royce F.
Full details of concise, diastereocontrolled syntheses of 2-5 and their incorporation into tri-, tetra-, and pentapeptide S, the C-terminus of bleomycin A2, are described. The extension of the studies to the synthesis of a complete set of tri- and tetrapeptide S structural analogs 29a,b and 43b-j is detailed, and their DNA binding constants (apparent K(B), calf thymus DNA) and apparent binding site sizes were determined. Consistent with past observations, the studies highlight the fact that the majority of the DNA binding affinity for bleomycin A2 (1.0 X 105 M-1) and deglycobleomycin A2 (1.1 x 105 M-1) is embodied within N-BOC-tripeptide S (0.26 x 105 M-1). The additional comparisons of 29a (0.18 x 105 M-1), N-BOC-tetrapeptide S (0.21 x 105 M-1), 43h (0.20 x 105 M-1), and N-BOC pentapeptide S (0.23 x 105 M-1) versus N-BOC-dipeptide S (0.10 x 105 M-1) indicate productive stabilizing binding interactions for the tripeptide S L-threonine subunit and substituent, illustrate that the entire pentanoic acid subunit of tetrapeptide S and its substituents do not significantly contribute to DNA binding affinity, and indicate that the entire β-hydroxy-L-histidine subunit of pentapeptides does not contribute to DNA binding affinity. With the exception of the L-threonine side chain substituent, the observations suggest that the tri- and tetrapeptide S substituent effects on the bleomycin A2 DNA cleavage reaction are not due to substantial stabilizing binding interactions with duplex DNA. In addition, the measured apparent binding site sizes for bleomycin A2 (3.8 base pairs), deglycobleomycin A2 (3.9 base pairs), N-BOC-tripeptide S (3.6 base pairs), N-BOC-tetrapeptide S (3.7 base pairs), 43h (3.5 base pairs), and N-BOC-pentapeptides (4.2 base pairs) versus N-BOC-dipeptide S (2.2 base pairs) and 29a (2.7 base pairs) suggest that it is the tripeptide S subunit of bleomycin A2 that is fully bound to duplex DNA, that the tripeptide S L-threonine hydroxyethyl substituent detectably affects the agent interaction with duplex DNA, but that the presence or absence of the other tetrapeptide S and pentapeptide S backbone substituents do not substantially alter the binding site size or tripeptide S binding mode.
View MoreZhejiang Tianyu Pharmaceutical Co., Ltd.
Contact:+86-576-84177669, 89189665,89189688,84168770
Address:Jiangkou Development Zone, Huangyan, Taizhou City, Zhejiang
Contact:+91 9963263336
Address:Plot#146A, IDA Mallapur, Hyderabad - 500072
JinTan Pingsheng Chemical Co.,Ltd
Contact:+86-519-82828200
Address:NO.11Danfengxilu Road,Jintan City,Jiangsu,China
SHANDONG ZHANHUA YONGHAO PHARMACEUTICAL TECH.CO.,LTD
Contact:+86-576-88685096
Address:GENGJU VILLAGE NORTH ONE KILOMETER,ZHANHUA DISTRICT,BINZHOU CITY,SHANDONG PROVINCE,CHINA.
Changzhou Ruiping Chemical Co., Ltd
website:http://www.wishchem.com
Contact:+86-519-82324280
Address:No.288-1 Huacheng Road, Jintan
Doi:10.1016/j.cclet.2017.09.058
(2018)Doi:10.1134/S107032841405011X
()Doi:10.1002/adsc.201301069
(2014)Doi:10.1134/S1070428014040290
()Doi:10.3109/14756366.2013.793184
(2014)Doi:10.1002/chem.201304690
(2014)